2 completed, 2 recruiting, 2 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 2, Recruiting 2, Terminated 2 |
Follow PET Scan: new trials by email Literature Review of PET Scan trials Research Report on PET Scan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial Biospecimen Collection, Computed Tomography, Cystectomy - Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma | Phase 4 | Recruiting | Mayo Clinic | 75 | 2025-01-08 | 2026-10-01 |
| An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 4 | Recruiting | City of Hope Medical Center | 10 | 2022-12-21 | 2026-07-01 |
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-09-19 | 2025-01-16 |
| Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases Fludeoxyglucose F-18, Magnetic Resonance Imaging, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 4 | Completed | M.D. Anderson Cancer Center | 12 | 2018-08-03 | 2024-05-01 |
| Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. Antidepressants, Positron Emission Tomography (PET) - Bulimia Nervosa | Phase 4 | Completed | Centre Hospitalier Universitaire de Saint Etienne | 51 | 2015-11-09 | 2022-11-30 |
| A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls Paliperidone ER, Oral risperidone, PET Scan - Schizophrenia | Phase 4 | Terminated | Janssen-Cilag G.m.b.H | 2 | 2009-09-01 | 2014-02-11 |
Brain Neoplasms (2) · Breast Neoplasms (1) · Bulimia (1) · Bulimia Nervosa (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Schizophrenia (1) · Ureteral Neoplasms (1) · Urinary Bladder Neoplasms (1)
M.D. Anderson Cancer Center (2) · Centre Hospitalier Universitaire de Saint Etienne (1) · City of Hope Medical Center (1) · Janssen-Cilag G.m.b.H (1) · Mayo Clinic (1)
United States (4) · France (1) · Germany (1)
Dawid Schellingerhout (1) · Gregory C Ravizzini (1) · Jacob J. Orme, MD, PhD (1) · Joanne E Mortimer (1) · Paras H. Shah, MD (1)
2015 (1), P30CA033572 (1)